University Health Network-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University Health Network - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013494
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibility, health records, hospitality services and volunteer resources. The organization conducts research in the fields of neurosciences, cardiology, oncology, transplantation, surgical innovation, genomic medicine, infectious diseases, and rehabilitation medicine. UHN is a network of health care and teaching institutions, namely, Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and The Michener Institute of Education at UHN. It is a research hospital affiliated to the University of Toronto. UHN is headquartered in Toronto, Ontario, Canada.

University Health Network – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University Health Network, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University Health Network, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University Health Network, Medical Devices Deals, 2011 to YTD 2017 10
University Health Network, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University Health Network, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
DLVR Therapeutics Secures Additional Investment In Seed Financing 12
Partnerships 13
Theralase Technologies Expands its Research Agreement with University Health Network 13
OncoTherics Enters into Agreement with University Health Network 14
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15
Licensing Agreements 16
VistaGen Therapeutics Enters into Licensing Agreement with University Health Network 16
VistaGen Therapeutics Enters Licensing Agreement with University Health Network 17
Sernova Enters into Licensing Agreement with University Health Network 18
Avrobio Enters into Licensing Agreement with University Health Network 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
Stem Cell Therapeutics Enters into Licensing Agreement with University Health Network 21
University Health Network – Key Competitors 22
University Health Network – Key Employees 23
University Health Network – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Government and Public Interest 25
Nov 23, 2017: Innovative Medicines Canada and Astellas Announce Grant to the University Health Network’s Transplant Innovation Fund 25
Nov 15, 2017: Molecular pathway offers treatment targets for pulmonary fibrosis, related conditions 26
Nov 06, 2017: UHN Vision Scientists Discover Potential Neuroprotective Treatment For Glaucoma 28
Oct 13, 2017: Neurotechnological innovation and organ-on-a-chip engineering centres receive more than $10 million in new funding 29
Nov 08, 2016: Blocking the Formation of a Cancer in the Brain 30
Aug 29, 2016: Breast cancer Researchers Look Beyond Genes to Find More Drivers of Disease Development 31
Aug 04, 2016: Research team discovers two biomarkers that contribute to spine osteoarthritis 32
Jul 14, 2016: Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood 33
Jul 14, 2016: Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood for future clinical use 34
Jun 28, 2016: Prostate cancer researchers use liquid biopsy biomarkers to identify aggressive disease before treatment 35
Apr 19, 2016: Breast cancer patients receiving Herceptin treatment should be monitored for heart damage at any age 36
Jan 07, 2016: Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario 37
Product News 38
Feb 06, 2017: Immune therapy scientists discover distinct cells that block cancer-fighting immune cells 38
Other Significant Developments 39
Apr 12, 2017: University Health Network: First-of-its-kind app offers personalized rehab therapy for stroke patients 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
University Health Network, Pharmaceuticals & Healthcare, Key Facts 2
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University Health Network, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University Health Network, Deals By Therapy Area, 2011 to YTD 2017 9
University Health Network, Medical Devices Deals, 2011 to YTD 2017 10
University Health Network, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
DLVR Therapeutics Secures Additional Investment In Seed Financing 12
Theralase Technologies Expands its Research Agreement with University Health Network 13
OncoTherics Enters into Agreement with University Health Network 14
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15
VistaGen Therapeutics Enters into Licensing Agreement with University Health Network 16
VistaGen Therapeutics Enters Licensing Agreement with University Health Network 17
Sernova Enters into Licensing Agreement with University Health Network 18
Avrobio Enters into Licensing Agreement with University Health Network 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
Stem Cell Therapeutics Enters into Licensing Agreement with University Health Network 21
University Health Network, Key Competitors 22
University Health Network, Key Employees 23
University Health Network, Subsidiaries 24

★海外企業調査レポート[University Health Network-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acona Holding AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Acona Holding AS (Acona) is an oil and gas company that offers well management and cleaning technology services. The company’s services include drilling and well technology services, exploration and production technology, field development, and oil and gas consulting services. It also provid …
  • Stamps com Inc (STMP):企業の財務・戦略的SWOT分析
    Stamps com Inc (STMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nobel Biocare Services AG:企業の製品パイプライン分析
    Summary Nobel Biocare Services AG (Nobel Biocare), a subsidiary of Danaher Corporation, is a provider of implant-based dental restorations. The company offers various solutions, including dental implant systems; high-precision individualized prosthetics; CAD/CAM systems; diagnostics and treatment pl …
  • The Emirates Group:企業の戦略・SWOT・財務分析
    The Emirates Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CommonSpirit Health:企業の戦略的SWOT分析
    CommonSpirit Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Sing Investments & Finance Limited (S35):企業の財務・戦略的SWOT分析
    Sing Investments & Finance Limited (S35) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Columbia University-製薬・医療分野:企業M&A・提携分析
    Summary Columbia University (CU) is an educational service provider that offers educational and research programs. The university provides educational services and courses through its schools, departments, faculties, centers and institutes. It provides undergraduate and graduate courses in various d …
  • Weifang Changan Steel Tower Stock Co Ltd:企業の戦略的SWOT分析
    Weifang Changan Steel Tower Stock Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Collagen Solutions Plc (COS):製品パイプライン分析
    Summary Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of f …
  • Africa Israel Investments Ltd:企業の戦略・SWOT・財務情報
    Africa Israel Investments Ltd - Strategy, SWOT and Corporate Finance Report Summary Africa Israel Investments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ono Pharmaceutical Co Ltd (4528):企業の財務・戦略的SWOT分析
    Ono Pharmaceutical Co Ltd (4528) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • R-Biopharm AG:医療機器:M&Aディール及び事業提携情報
    Summary R-Biopharm AG (R-Biopharm), a subsidiary of Rohm Gmbh & Co KG, is a developer of test solutions for clinical diagnostics and food and feed analysis. The company offers test systems in the areas of infectological stool diagnostics, serological infection and allergy diagnostics for clinical di …
  • Targa Resources Corp (TRGP):企業の財務・戦略的SWOT分析
    Targa Resources Corp (TRGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Energia Argentina SA:電力:M&Aディール及び事業提携情報
    Summary Energia Argentina SA (ENARSA) is a state owned energy company that explores and exploits hydrocarbons in solid, liquid and gaseous states. It stores, transports, distributes, markets and industrializes the hydrocarbons and their derivatives. Energia conducts design, construction, commissioni …
  • Packaging Corporation of America (PKG):企業の財務・戦略的SWOT分析
    Packaging Corporation of America (PKG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Cofidis Participations S.A.
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Noble Mineral Exploration Inc (NOB):企業の財務・戦略的SWOT分析
    Summary Noble Mineral Exploration Inc (Noble Mineral) is a mining and mineral exploration and development company that offers mineral resources. The company offers acquisition, exploration mining, production, and development of gold, nickel, copper, zinc, uranium, and mineral resources deposit prope …
  • Takenaka Corporation:企業の戦略・SWOT・財務情報
    Takenaka Corporation - Strategy, SWOT and Corporate Finance Report Summary Takenaka Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CWC Energy Services Corp (CWC):石油・ガス:M&Aディール及び事業提携情報
    Summary CWC Energy Services Corp (CWC), formerly CWC Well Services Corp, is an oilfield servicing company that provides drilling rigs, service rigs, coil tubing and well testing services in the Western Canadian Sedimentary Basin. The company operates through two divisions such as contract drilling a …
  • Avillion LLP-製薬・医療分野:企業M&A・提携分析
    Summary Avillion LLP (Avillion) is a provider of drug development services. The company supports pharmaceutical and biotechnology companies to develop drug candidates without increasing the burden on them. It maintains a business model for the clinical development and regulatory approval of late sta …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆